GILD

Gilead Sciences
GILD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$128.62B
EV
$145.70B
Shares Outstanding
1.25B
Beta
0.34

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$113.75
P/E 2025E
12.96x
P/Revenue 2025E
4.49x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Gilead Sciences, Inc.

gainify
GILD

Gilead Sciences, Inc.

GILD

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Evi...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

O'Day, Daniel P.

Employees

17,600

IPO Date

1992-01-22

Headquarters

333 Lakeside Drive, Foster City, California, 94404, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved